Table 1 Characteristics of subjects enrolled.

From: Identification of a key gene module associated with glucocorticoid- induced derangement in bone mineral density in patients with asthma

 

Childhood asthmatics† (n = 32)

Adult asthmatics‡ (n = 17)

Gender, male (%)

23 (71.9)

6 (35.3)

Age, year

8.63 (1.93)

60.11 (11.71)

Smoking, yes (%)

Not applicable

3 (17.65)

Body mass index, kg/m2

17.71 (3.21)

23.72 (5.18)

Vitamin D, ng/mL

31.81 (9.97)

14.71 (7.72)

Tanner stage (%)

I/II/III/IV/V

24 (75.0)/6 (18.8)/1(3.1)/1 (3.1)

Not applicable

Baseline BMD Z-score

−0.10 (2.23)

Not available

Ethnicity (%)

Non-Hispanic white

32 (100)

0

Asian

0

17 (100)

Cumulative dose of PD, mg

1188.40 (608.05)

3130.53 (1552.09)

Final BMD Z-score

−0.29 (0.81)

−0.97 (1.37)

  1. Data indicate mean (Standard deviation); BMD, Bone mineral density; PD, Prednisone; †Characteristics measured at enrollment of the CAMP study except cumulative dose of prednisone and the final BMD Z-score; ‡Characteristics measured at enrollment of the present study.
Back to article page